↓ Skip to main content

Dove Medical Press

Article Metrics

Mesalazine-induced eosinophilic pneumonia with bone marrow infiltration: a case report and literature review

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
8 Mendeley
Title
Mesalazine-induced eosinophilic pneumonia with bone marrow infiltration: a case report and literature review
Published in
Therapeutics and Clinical Risk Management, June 2016
DOI 10.2147/tcrm.s107012
Pubmed ID
Authors

Yunjian Zhang, Ling Luo, Xiaoyang Liu, Xiaoyan Wang, Yi Ding, Xiaofang Wang

Abstract

Mesalazine-induced eosinophilic pneumonia has been rarely reported. We reported a case of mesalazine-induced eosinophilic pneumonia in a 56-year-old female who took mesalazine without a prescription for suspected ulcerative colitis. She had an elevated eosinophil count in peripheral blood and bronchoalveolar lavage fluid. Eosinophil infiltration was also noted in bone marrow aspirates. Chest radiograph and computed tomography demonstrated bilateral upper lung predominant infiltrates and spirometry showed a restrictive ventilatory defect with a reduced diffusion capacity. The patient recovered after cessation of mesalazine therapy. Mesalazine-induced lung damage should be considered in patients who develop unexplained respiratory symptoms while taking this agent.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 25%
Student > Master 2 25%
Student > Doctoral Student 2 25%
Researcher 1 13%
Other 1 13%
Other 0 0%
Readers by discipline Count As %
Medicine and Dentistry 4 50%
Unspecified 2 25%
Nursing and Health Professions 1 13%
Pharmacology, Toxicology and Pharmaceutical Science 1 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 June 2016.
All research outputs
#7,834,178
of 12,485,238 outputs
Outputs from Therapeutics and Clinical Risk Management
#642
of 922 outputs
Outputs of similar age
#144,031
of 265,309 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#40
of 52 outputs
Altmetric has tracked 12,485,238 research outputs across all sources so far. This one is in the 23rd percentile – i.e., 23% of other outputs scored the same or lower than it.
So far Altmetric has tracked 922 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 265,309 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.